| Bellevue Hospital Center | |
| 462 First Avenue, New York, New York 10016 | |
| (212) 562-4141 | |
| Name | Bellevue Hospital Center |
|---|---|
| Type | Acute Care Hospital |
| Location | 462 First Avenue, New York, New York |
| Ownership | Government - Local |
| Emergency Services | Yes |
| Medicare ID (CCN) | 330204 |
| NPI Number | 1215064993 |
| Organization Name | NYU MEDICAL CENTER |
| Address | 462 1st Ave, New York, NY 10016 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 121-256-2222 |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
The latest issue of GIE: Gastrointestinal Endoscopy, the official journal of the American Society for Gastrointestinal Endoscopy, includes a new society guideline on use of endoscopic eradication therapy Barrett's esophagus.
Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues. The reason for this or this association has been hitherto unexplained. According to a new study from MIT and the Whitehead Institute, the process of healing of the surgical scar after surgery is the cause for spread of the cancer.
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
› Verified 4 days ago
| NPI Number | 1255652871 |
| Organization Name | BELLEVUE HOSPITAL CENTER |
| Address | 462 1st Ave, New York, NY 10016 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 212-263-6219 |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
The latest issue of GIE: Gastrointestinal Endoscopy, the official journal of the American Society for Gastrointestinal Endoscopy, includes a new society guideline on use of endoscopic eradication therapy Barrett's esophagus.
Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues. The reason for this or this association has been hitherto unexplained. According to a new study from MIT and the Whitehead Institute, the process of healing of the surgical scar after surgery is the cause for spread of the cancer.
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
› Verified 4 days ago
| NPI Number | 1275680860 |
| Organization Name | BELLEVUE HOSPITAL CENTER |
| Address | 104 E 40th St, Suite 602, New York, NY 10016 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 212-681-9790 |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
The latest issue of GIE: Gastrointestinal Endoscopy, the official journal of the American Society for Gastrointestinal Endoscopy, includes a new society guideline on use of endoscopic eradication therapy Barrett's esophagus.
Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues. The reason for this or this association has been hitherto unexplained. According to a new study from MIT and the Whitehead Institute, the process of healing of the surgical scar after surgery is the cause for spread of the cancer.
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
› Verified 4 days ago
| NPI Number | 1396944328 |
| Organization Name | NEW YORK UNIVERSITY SCHOOL OF MEDICINE |
| Address | 462 1st Ave, New York, NY 10016 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 212-263-3888 |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
The latest issue of GIE: Gastrointestinal Endoscopy, the official journal of the American Society for Gastrointestinal Endoscopy, includes a new society guideline on use of endoscopic eradication therapy Barrett's esophagus.
Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues. The reason for this or this association has been hitherto unexplained. According to a new study from MIT and the Whitehead Institute, the process of healing of the surgical scar after surgery is the cause for spread of the cancer.
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
› Verified 4 days ago
| NPI Number | 1518170463 |
| Organization Name | BELLEVUE HOSPITAL CENTER |
| Address | 30 Waterside Plz, 23c, New York, NY 10010 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 212-725-2923 |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
The latest issue of GIE: Gastrointestinal Endoscopy, the official journal of the American Society for Gastrointestinal Endoscopy, includes a new society guideline on use of endoscopic eradication therapy Barrett's esophagus.
Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues. The reason for this or this association has been hitherto unexplained. According to a new study from MIT and the Whitehead Institute, the process of healing of the surgical scar after surgery is the cause for spread of the cancer.
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
› Verified 4 days ago
| NPI Number | 1578853925 |
| Organization Name | BELLEVUE HOSPITAL CENTER |
| Address | 462 First Avenue, Bellevue Hospital Center-department Of Social Work, New York, NY 10016 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 212-562-2644 |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
The latest issue of GIE: Gastrointestinal Endoscopy, the official journal of the American Society for Gastrointestinal Endoscopy, includes a new society guideline on use of endoscopic eradication therapy Barrett's esophagus.
Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues. The reason for this or this association has been hitherto unexplained. According to a new study from MIT and the Whitehead Institute, the process of healing of the surgical scar after surgery is the cause for spread of the cancer.
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
› Verified 4 days ago
| NPI Number | 1619282431 |
| Organization Name | BELLEVUE HOSPITAL CENTER HHC |
| Address | 462 1st Ave, New York, NY 10016 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 121-256-2414 |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
The latest issue of GIE: Gastrointestinal Endoscopy, the official journal of the American Society for Gastrointestinal Endoscopy, includes a new society guideline on use of endoscopic eradication therapy Barrett's esophagus.
Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues. The reason for this or this association has been hitherto unexplained. According to a new study from MIT and the Whitehead Institute, the process of healing of the surgical scar after surgery is the cause for spread of the cancer.
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
› Verified 4 days ago
| NPI Number | 1639234198 |
| Organization Name | BELLEVUE HOSPITAL CENTER |
| Address | 462 1st Ave, New York, NY 10016 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 212-263-6425 |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
The latest issue of GIE: Gastrointestinal Endoscopy, the official journal of the American Society for Gastrointestinal Endoscopy, includes a new society guideline on use of endoscopic eradication therapy Barrett's esophagus.
Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues. The reason for this or this association has been hitherto unexplained. According to a new study from MIT and the Whitehead Institute, the process of healing of the surgical scar after surgery is the cause for spread of the cancer.
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
› Verified 4 days ago
| NPI Number | 1689736449 |
| Organization Name | BELLEVUE HOSPITAL CENTER |
| Address | 462 1st Ave, New York, NY 10016 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 212-263-6425 |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
The latest issue of GIE: Gastrointestinal Endoscopy, the official journal of the American Society for Gastrointestinal Endoscopy, includes a new society guideline on use of endoscopic eradication therapy Barrett's esophagus.
Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues. The reason for this or this association has been hitherto unexplained. According to a new study from MIT and the Whitehead Institute, the process of healing of the surgical scar after surgery is the cause for spread of the cancer.
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
› Verified 4 days ago
| NPI Number | 1730213042 |
| Organization Name | BELLEVUE HOSPITAL CENTER |
| Address | 462 1st Ave, Room # 12 East 12, New York, NY 10016 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 212-562-5131 |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
The latest issue of GIE: Gastrointestinal Endoscopy, the official journal of the American Society for Gastrointestinal Endoscopy, includes a new society guideline on use of endoscopic eradication therapy Barrett's esophagus.
Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues. The reason for this or this association has been hitherto unexplained. According to a new study from MIT and the Whitehead Institute, the process of healing of the surgical scar after surgery is the cause for spread of the cancer.
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
› Verified 4 days ago
| NPI Number | 1730404468 |
| Organization Name | BELLEVUE HOSPITAL CENTER |
| Address | 452 1st Ave, New York, NY 10016 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 212-562-0000 |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
The latest issue of GIE: Gastrointestinal Endoscopy, the official journal of the American Society for Gastrointestinal Endoscopy, includes a new society guideline on use of endoscopic eradication therapy Barrett's esophagus.
Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues. The reason for this or this association has been hitherto unexplained. According to a new study from MIT and the Whitehead Institute, the process of healing of the surgical scar after surgery is the cause for spread of the cancer.
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
› Verified 4 days ago
| NPI Number | 1740693530 |
| Organization Name | BELLEVUE HOSPITAL CENTER |
| Address | 462 1st Ave, New York, NY 10016 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 212-562-6501 |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
The latest issue of GIE: Gastrointestinal Endoscopy, the official journal of the American Society for Gastrointestinal Endoscopy, includes a new society guideline on use of endoscopic eradication therapy Barrett's esophagus.
Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues. The reason for this or this association has been hitherto unexplained. According to a new study from MIT and the Whitehead Institute, the process of healing of the surgical scar after surgery is the cause for spread of the cancer.
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
› Verified 4 days ago
| NPI Number | 1780138974 |
| Organization Name | NYULANGONEMEDICALCENTER |
| Address | 462 1st Ave, Nbv-8s3, New York, NY 10016 |
| Hospital Type | General Acute Care Hospital - Children |
| Phone Number | 212-263-7822 |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
The latest issue of GIE: Gastrointestinal Endoscopy, the official journal of the American Society for Gastrointestinal Endoscopy, includes a new society guideline on use of endoscopic eradication therapy Barrett's esophagus.
Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues. The reason for this or this association has been hitherto unexplained. According to a new study from MIT and the Whitehead Institute, the process of healing of the surgical scar after surgery is the cause for spread of the cancer.
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
› Verified 4 days ago
| NPI Number | 1841324126 |
| Organization Name | NEW YORK CITY HEALTH AND HOSPITALS CORPORATION |
| Address | 462 1st Ave, New York, NY 10016 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 212-562-3924 |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
The latest issue of GIE: Gastrointestinal Endoscopy, the official journal of the American Society for Gastrointestinal Endoscopy, includes a new society guideline on use of endoscopic eradication therapy Barrett's esophagus.
Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues. The reason for this or this association has been hitherto unexplained. According to a new study from MIT and the Whitehead Institute, the process of healing of the surgical scar after surgery is the cause for spread of the cancer.
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
› Verified 4 days ago
| NPI Number | 1912212366 |
| Organization Name | BELLEVUE HOPITAL |
| Address | 462 1st Ave, New York, NY 10016 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 212-562-5762 |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
The latest issue of GIE: Gastrointestinal Endoscopy, the official journal of the American Society for Gastrointestinal Endoscopy, includes a new society guideline on use of endoscopic eradication therapy Barrett's esophagus.
Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues. The reason for this or this association has been hitherto unexplained. According to a new study from MIT and the Whitehead Institute, the process of healing of the surgical scar after surgery is the cause for spread of the cancer.
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
› Verified 4 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
The latest issue of GIE: Gastrointestinal Endoscopy, the official journal of the American Society for Gastrointestinal Endoscopy, includes a new society guideline on use of endoscopic eradication therapy Barrett's esophagus.
Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues. The reason for this or this association has been hitherto unexplained. According to a new study from MIT and the Whitehead Institute, the process of healing of the surgical scar after surgery is the cause for spread of the cancer.
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
› Verified 4 days ago
Mount Sinai Hospital Acute Care Hospital Location: One Gustave L Levy Place, New York, New York 10029 Phone: (212) 241-7981 | |
Mount Sinai St Luke's Roosevelt Hospital Acute Care Hospital Location: 1000 Tenth Avenue, New York, New York 10019 Phone: (212) 523-4000 | |
Ny Eye And Ear Infirmary Of Mount Sinai Acute Care Hospital Location: 230 Second Ave, New York, New York 10003 Phone: (212) 979-4000 | |
New York-presbyterian Hospital Acute Care Hospital Location: 525 East 68th Street, New York, New York 10065 Phone: (212) 746-5454 | |
Lenox Hill Hospital Acute Care Hospital Location: 100 East 77th Street, New York, New York 10021 Phone: (212) 439-2345 | |
Mount Sinai Beth Israel Acute Care Hospital Location: First Avenue At 16th Street, New York, New York 10003 Phone: (212) 420-2000 |